Dietary Potassium liberalization with fruit and vegetables versus potassium restriction in people with Chronic Kidney Disease (DK-Lib CKD): a clinical trial protocol

Author:

Iman Yasmin1,Balshaw Robert2,Alexiuk Mackenzie2,Hingwala Jay3,Cahill Leah4,Mollard Rebecca1,Tangri Navdeep2,Mackay Dylan5

Affiliation:

1. Chronic Disease Innovation Centre

2. University of Manitoba, Max Rady College of Medicine, Department of Community Health Sciences

3. University of Manitoba, Max Rady College of Medicine, Department of Internal Medicine

4. Dalhousie University, Department of Medicine

5. University of Manitoba, Faculty of Agriculture and Food Sciences, Department of Food and Human Nutritional Sciences

Abstract

Abstract Background: Potassium regulation in the body is primarily done in the kidney. In addition to this, hyperkalemia, occurs in approximately 10% of individuals with chronic kidney disease (CKD) and is associated with elevated all-cause mortality. Individuals with CKD are often told to restrict dietary potassium (K), however, this recommendation is based on low quality evidence. Reduced quality of life, limited dietary choices and nutritional deficiencies are all potential negative outcomes that may occur when restricting dietary K in CKD patients. There is a need for randomized controlled trials investigating the impact of dietary K modification on serum K concentrations in people with CKD. Methods: A randomized 2-period crossover design comparing a liberalized K fruit and vegetable diet where participants will be required to consume ~ 3500 mg of dietary K daily, to a standard K restricted diet where participants will be required to consume < 2000 mg of dietary K daily. All participants will begin on a liberalized K run-in period for 2 weeks where they will receive fruit and vegetables home deliveries and for safety will have clinical chemistry, including serum potassium measurements taken after 1 week. Participants will then be randomized into either liberalized K or standard K diet for six weeks and then crossover to the other intervention for another 6 weeks after a 2-week washout period. Discussion: 30 male and female CKD outpatients, ≥18 years of age, who have an estimated glomerular filtration rate (eGFR) between 15 and 45 ml/min/1.73m2 and serum K between 4.5 and 5.5 mEq/L. This design would have greater than 80% power to detect a difference of 0.35 mEq/L serum K between groups. Anthropometric measurements, clinical chemistry, dietary recalls, physical function assessments, as well as a quality of life assessments will also be measured in this trial. These findings will provide high quality evidence for, or against, recommendations for dietary K restriction in individuals living with CKD. The removal of K restriction could provide individuals living with CKD more dietary choice leading to improved dietary status and quality of life. Trial Registration: This trial has received approval from the University of Manitoba Research Ethics board (HS25191 (B2021:104)).

Publisher

Research Square Platform LLC

Reference16 articles.

1. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis;Hill NR;PLoS ONE,2016

2. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey;Arora P;CMAJ,2013

3. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;GBD Chronic Kidney Disease Collaboration;Lancet,2020

4. Mantilla SJL. Impact of ACEi/ARB Discontinuation after an Episode of Hyperkalemia in Patients with Chronic Kidney Disease. A Population-Based Cohort Study. MSc. University of Manitoba; 2020. https://mspace.lib.umanitoba.ca/server/api/core/bitstreams/1e4e7385-364f-4707-a9cf-38000c528b67/content.

5. Ambulatory Treatments for RAAS Inhibitor–Related Hyperkalemia and the 1-Year Risk of Recurrence;Hundemer GL;Clin J Am Soc Nephrol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3